Adamas to Present at Upcoming September Investor Conferences

Rhea-AI Summary

Adamas Pharmaceuticals (NASDAQ: ADMS) will present at two virtual investor conferences in September 2021. The first, the H.C. Wainwright 23rd Annual Global Investment Conference, features a pre-recorded presentation available from September 13 at 7:00 am ET. The second, the Cantor Fitzgerald Global Healthcare Conference, is scheduled for September 29 at 4:40 pm ET. Replays will be accessible on the company's investor relations webpage for about 30 days. Adamas focuses on innovative treatments for neurological diseases.

EMERYVILLE, Calif.--(BUSINESS WIRE)-- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that management will present at the following virtual investor conferences during the month of September 2021:

• H.C. Wainwright 23rd Annual Global Investment Conference, a pre-recorded presentation will be available beginning on Monday, September 13 at 7:00 am ET (4:00 am PT)

• Cantor Fitzgerald Global Healthcare Conference, on Wednesday, September 29 at 4:40 pm ET (1:40 pm PT)

Replays of both events will be available on the investor relations section of the Adamas website at http://ir.adamaspharma.com/events-presentations. The replays will remain available for approximately 30 days from their original posting.

About Adamas Pharmaceuticals, Inc.

At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and, society. We are a fully-integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit www.adamaspharma.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210830005541/en/

Media:

Sarah Mathieson

Vice President, Corporate Communications

510-450-3528

smathieson@adamaspharma.com



Investors:

Peter Vozzo

Managing Director

Westwicke/ICR

443-213-0505

peter.vozzo@westwicke.com

Source: Adamas Pharmaceuticals, Inc.

FAQ

When will Adamas Pharmaceuticals present at the H.C. Wainwright Global Investment Conference?

Adamas Pharmaceuticals will present a pre-recorded presentation at the H.C. Wainwright 23rd Annual Global Investment Conference starting September 13, 2021, at 7:00 am ET.

What time is Adamas Pharmaceuticals' presentation at the Cantor Fitzgerald Global Healthcare Conference?

The Cantor Fitzgerald Global Healthcare Conference presentation by Adamas Pharmaceuticals is scheduled for September 29, 2021, at 4:40 pm ET.

Where can I find replays of Adamas Pharmaceuticals' conference presentations?

Replays of Adamas Pharmaceuticals' presentations will be available on their investor relations website at http://ir.adamaspharma.com/events-presentations for approximately 30 days from posting.

What is the focus of Adamas Pharmaceuticals?

Adamas Pharmaceuticals is dedicated to developing innovative medicines for neurological diseases, aiming to reduce the burden on patients and caregivers.